Miran Özdogan

Benjamin Ballyk, Teyun Kwon, Miran Özdogan et al.

Non-invasive brain-to-speech decoding aims to restore communication to patients suffering from neurodegenerative disease, without the risks of neurosurgery. Existing MEG- and EEG-based methods, while scalable, continue to suffer from high word error rates driven by relatively low signal-to-noise ratios compared to invasive recordings. We propose physiological noise augmentation (PNA), a data augmentation method that explicitly trains decoders to become invariant to task-agnostic artifacts (e.g. ocular and cardiac activity). PNA draws inspiration from automatic speech recognition systems, where environmental noise (e.g. dogs barking, city traffic) is added to clean speech to improve robustness. Analogously, we decompose brain recordings into clean data and noise artifacts using independent component analysis (ICA), before scaling and remixing to generate biophysically realistic, label-preserving training examples. We show that PNA approximates anisotropic regularization, penalizing decoder sensitivity along artifact-dominated directions. On MegNIST, a 12k-trial imagined-digit MEG dataset, PNA with 10-trial averaging improves EEGNet decoding accuracy by 4.7 percentage points (absolute) over training on real data alone. Our results suggest that artifact-aware augmentation and trial averaging are complementary tools for improving robustness in non-invasive speech BCIs.

Gilad Landau, Miran Özdogan, Gereon Elvers et al.

The advance of speech decoding from non-invasive brain data holds the potential for profound societal impact. Among its most promising applications is the restoration of communication to paralysed individuals affected by speech deficits such as dysarthria, without the need for high-risk surgical interventions. The ultimate aim of the 2025 PNPL competition is to produce the conditions for an "ImageNet moment" or breakthrough in non-invasive neural decoding, by harnessing the collective power of the machine learning community. To facilitate this vision we present the largest within-subject MEG dataset recorded to date (LibriBrain) together with a user-friendly Python library (pnpl) for easy data access and integration with deep learning frameworks. For the competition we define two foundational tasks (i.e. Speech Detection and Phoneme Classification from brain data), complete with standardised data splits and evaluation metrics, illustrative benchmark models, online tutorial code, a community discussion board, and public leaderboard for submissions. To promote accessibility and participation the competition features a Standard track that emphasises algorithmic innovation, as well as an Extended track that is expected to reward larger-scale computing, accelerating progress toward a non-invasive brain-computer interface for speech.

Miran Özdogan, Gilad Landau, Gereon Elvers et al.

LibriBrain represents the largest single-subject MEG dataset to date for speech decoding, with over 50 hours of recordings -- 5$\times$ larger than the next comparable dataset and 50$\times$ larger than most. This unprecedented `depth' of within-subject data enables exploration of neural representations at a scale previously unavailable with non-invasive methods. LibriBrain comprises high-quality MEG recordings together with detailed annotations from a single participant listening to naturalistic spoken English, covering nearly the full Sherlock Holmes canon. Designed to support advances in neural decoding, LibriBrain comes with a Python library for streamlined integration with deep learning frameworks, standard data splits for reproducibility, and baseline results for three foundational decoding tasks: speech detection, phoneme classification, and word classification. Baseline experiments demonstrate that increasing training data yields substantial improvements in decoding performance, highlighting the value of scaling up deep, within-subject datasets. By releasing this dataset, we aim to empower the research community to advance speech decoding methodologies and accelerate the development of safe, effective clinical brain-computer interfaces.